Visitors Now:
Total Visits:
Total Stories:
Profile image
By ProactiveInvestors (Reporter)
Contributor profile | More stories
Story Views

Now:
Last Hour:
Last 24 Hours:
Total:

VolitionRx says test can slash colorectal cancer ‘false positives’

Tuesday, October 11, 2016 7:41
% of readers think this story is Fact. Add your two cents.

(Before It's News)

Use of its NuQ blood tests alongside traditional colorectal cancer screens can reduce the number of colonoscopies by a quarter, according to VolitionRx Limited (NYSE MKT:VNRX).

Presenting to the European Society for Medical Oncology Congress (ESMO), Volition Rx said a combination of an NuQ to test for colorectal cancer (CRC) combined with the conventional faecal immunochemical screening test registered almost a 97% detection for colorectal cancer.

Marielle Herzog, Volition’s lead nucleosomic scientist, said: “False positives add to an already long waiting list and delays diagnosis for patients who have cancer and need swift treatment.

“By undertaking this simple, cost effective blood test in people with a positive faecal test, we can help prevent unneeded referrals for colonoscopy with a small reduction in cancer detection and potentially reduce the colonoscopy waiting time for those at high risk of cancer.”

Using NuQ with a faecal test can also increase screening subject throughput by a third.

Volition plans initially to focus the launch in large European Union countries.

It expects to receive CE Marking for this test later this year and to market the CRC test throughout Europe in 2017.

Story by ProactiveInvestors

Report abuse

Comments

Your Comments
Question   Razz  Sad   Evil  Exclaim  Smile  Redface  Biggrin  Surprised  Eek   Confused   Cool  LOL   Mad   Twisted  Rolleyes   Wink  Idea  Arrow  Neutral  Cry   Mr. Green

Top Stories
Recent Stories

Register

Newsletter

Email this story
Email this story

If you really want to ban this commenter, please write down the reason:

If you really want to disable all recommended stories, click on OK button. After that, you will be redirect to your options page.